Resources Contact Us Home
Controlled release biodegradable micro- and nanospheres containing cyclosporin

Image Number 2 for United States Patent #5641745.

A controlled release pharmaceutical formulation which comprises cyclosporin entrapped in a biodegradable polymer to form microspheres or nanospheres such that the cyclosporin is substantially in an amorphous state and the biodegradable polymer comprises greater than 12.5% w/w poly(lactide). The biodegradable polymer is suitably poly-D,L-lactide or a blend of poly-D,L-lactide and poly-D,L-lactide-co-glycolide. Additionally, an enteric coating can be applied to the microspheres or nanospheres or to the oral dosage form incorporating the microspheres or nanospheres to protect the formulation while it passes through the stomach. A particularly suitable formulation comprises 50% w/w cyclosporin-loaded 80:20 blend of poly-D,L-lactide-co-glycolide to poly-D,L-lactide micro- and/or nanospheres. This formulation has the combined properties of nearly complete but relatively slow release of cyclosporin within 8 hours and is useful for targeting cyclosporin to the small intestine when administered orally.

  Recently Added Patents
Automatic portable electronic device configuration
Heat retaining device
Gas flow indicator
Mechanism for visible users and groups
Integrated process for the manufacture of fluorinated olefins
Modular connector for touch sensitive device
Navigation apparatus, search result display method, and graphical user interface
  Randomly Featured Patents
Audio control apparatus
Finger toy
Method of repairing directionally solidified and single crystal alloy parts
Air powered vehicle
Combined sofa and adjustable legrest
Portion of a zipper pull
Balance with motor-driven wind guard
Detergent / anti-oxidant additives for fuels and lubricants
Semiconductor device with impurity layer to prevent depletion layer expansion
Liquid crystal display device having liquid crystal layer in which liquid crystal molecules are homogeneously oriented